GlassScriptPhysician profile
Ayham J Farha
NPI 1982682753
$7,605.71
in general payments reported to CMS, 2019-2025
47 companies · $796 in 2025
The $796 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,715 · 2020: $639 · 2021: $1,276 · 2022: $870 · 2023: $536 · 2024: $774 · 2025: $796.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,906 · Education: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,905.83 |
| Education | $199.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $1,486.09 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Janssen Biotech, INC. | $641.00 | 2019-2025 | Erleada, Balversa, Akeega |
| Astellas Pharma US INC | $535.70 | 2019-2022 | |
| Abbvie INC. | $411.03 | 2019-2023 | |
| Boston Scientific Corporation | $366.77 | 2019-2025 | Ams 700, Rezum Generator |
| Pfizer INC. | $315.69 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $233.59 | 2022-2025 | |
| Intuitive Surgical, INC. | $231.44 | 2019 | |
| Amgen INC. | $220.75 | 2019-2021 | |
| Tolmar Pharmaceuticals, INC. | $217.52 | 2021-2022 | |
| Medtronic, INC. | $206.99 | 2021-2022 | |
| Janssen Scientific Affairs, LLC | $168.49 | 2019 | |
| Antares Pharma, INC. | $157.55 | 2019-2021 | |
| Immunitybio, INC. | $156.01 | 2025 | |
| Laborie Medical Technologies Corp. | $145.21 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $125.35 | 2019-2024 | Speedicath, Porges Coloplast |
| Procept Biorobotics Corporation | $122.46 | 2022-2024 | Aquabeam System |
| Axonics, INC. | $114.39 | 2022-2023 | Bulkamid |
| Sumitomo Pharma America, INC. | $108.97 | 2023-2025 | Gemtesa |
| Endo Pharmaceuticals INC. | $108.70 | 2019-2021 | |
| Siemens Medical Solutions USA, INC. | $107.38 | 2021-2024 | Truebeam |
| Dendreon Pharmaceuticals LLC | $97.21 | 2020-2023 | Provenge |
| Myovant Sciences INC. | $92.56 | 2021 | |
| Clarus Therapeutics INC. | $92.43 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $89.61 | 2022-2024 | |
| Olympus America INC. | $88.30 | 2022-2025 | Soltive, Bovie, Olympus |
| Urogen Pharma, INC. | $87.85 | 2021-2025 | |
| Neotract INC. | $78.07 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $75.91 | 2019-2025 | Adstiladrin |
| Urovant Sciences INC | $73.85 | 2021-2022 | |
| Blue Earth Diagnostics | $70.61 | 2019-2021 | |
| Allergan, INC. | $63.88 | 2020-2021 | |
| Calyxo, INC. | $62.05 | 2024-2025 | Cvac Aspiration System |
| Progenics Pharmaceuticals, INC. | $53.11 | 2022 | |
| Conmed Corporation | $50.00 | 2019 | |
| Karl Storz Endoscopy-America | $48.69 | 2019 | |
| Myriad Genetic Laboratories, INC. | $48.53 | 2021-2023 | Prolaris |
| Photocure INC | $45.18 | 2019 | |
| Alnylam Pharmaceuticals INC. | $38.67 | 2024-2025 | Oxlumo, Givlaari |
| Verity Pharmaceuticals INC. | $33.88 | 2023-2024 | Trelstar |
| Genzyme Corporation | $28.01 | 2023 | |
| Teleflex LLC | $22.67 | 2025 | Barrigel |
| Davol INC. | $22.16 | 2019 | |
| Heron Therapeutics, INC. | $18.13 | 2023 | Zynrelef |
| Telix Pharmaceuticals | $16.23 | 2025 | Illuccix |
| Ambu INC. | $15.44 | 2025 | |
| Janssen Pharmaceuticals, INC | $11.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ayham Farha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.